Your session is about to expire
← Back to Search
N/A
Gluten Challenge for Celiac Disease
N/A
Recruiting
Led By Bana Jabri, MD
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Gluten de-challenge group: Age 18 to 70 years old, Showing typical celiac disease symptoms, Not on a gluten-free diet
Control group: Age 18 to 70 years old, Females who are not pregnant
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline -12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will study how celiac disease is caused and affects people, so better treatments can be developed for those with it.
Who is the study for?
Adults aged 18-70 with celiac disease can join this trial. Participants must have been diagnosed by biopsy at least a year ago and followed a strict gluten-free diet for the past year. Pregnant women, those with chronic GI diseases, uncontrolled blood disorders, or severe reactions to gluten are excluded.
What is being tested?
The study is testing how eating a gluten-containing snack bar affects people with celiac disease. It looks at tissue damage and healing by examining interactions between gut cells, microbes, immune responses, genetics, and gluten.
What are the potential side effects?
Eating the gluten snack may cause typical celiac symptoms like stomach pain, bloating, diarrhea or constipation in participants since they have been following a strict gluten-free diet.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18-70, have celiac symptoms, and am not on a gluten-free diet.
Select...
I am between 18 and 70 years old and not pregnant.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline -12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline -12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Gluten challenge group: quantitative analysis of intestinal villus to crypt ratios
Gluten de-challenge group: quantitative analysis of intestinal villus to crypt ratios
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Gluten challenge groupExperimental Treatment1 Intervention
Diagnosis of celiac disease by intestinal biopsy and serology for at least 12 months
Group II: Gluten de-challenge groupActive Control1 Intervention
Suspected celiac disease either showing typical symptoms or positive celiac disease serology
Group III: Control groupActive Control1 Intervention
No history or symptoms of celiac disease
Find a Location
Who is running the clinical trial?
Mayo ClinicOTHER
3,362 Previous Clinical Trials
3,065,741 Total Patients Enrolled
9 Trials studying Celiac Disease
4,328 Patients Enrolled for Celiac Disease
California Institute of TechnologyOTHER
16 Previous Clinical Trials
4,129 Total Patients Enrolled
University of ChicagoLead Sponsor
1,062 Previous Clinical Trials
839,916 Total Patients Enrolled
1 Trials studying Celiac Disease
1,090 Patients Enrolled for Celiac Disease
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,464 Previous Clinical Trials
4,337,233 Total Patients Enrolled
3 Trials studying Celiac Disease
234 Patients Enrolled for Celiac Disease
Bana Jabri, MDPrincipal InvestigatorUniversity of Chicago
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I was diagnosed with Celiac disease over a year ago through a biopsy.I do not have severe celiac complications, other chronic GI diseases, IgA deficiency, severe gluten reactions, significant diseases, substance or alcohol abuse issues, pregnancy or lactation, or blood clotting disorders.I am 18-70, diagnosed with Celiac via biopsy over a year ago, and have been strictly gluten-free for the last 12 months.I am 18-70, have celiac symptoms, and am not on a gluten-free diet.I do not have a history of chronic GI diseases, uncontrolled blood disorders, significant diseases, or substance abuse.I am taking certain medications like antibiotics or aspirin, have had gastrointestinal surgery, or have a family history of celiac disease.I am between 18 and 70 years old and not pregnant.I show symptoms common in celiac disease.You have been following a gluten-free diet for at least 12 months.You are not following a diet that excludes gluten.
Research Study Groups:
This trial has the following groups:- Group 1: Gluten challenge group
- Group 2: Gluten de-challenge group
- Group 3: Control group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.